FineMark National Bank & Trust’s Pacific Biosciences PACB Stock Holding History

FineMark National Bank & Trust’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,000	Closed	-$55K	–	1440
2014 Q4	$55K	Buy	+7,000	New	+$44.8K	0.01%	637
2014 Q2	–	Sell	-10,000	Closed	-$54K	–	1437
2014 Q1	$54K	Sell	10,000 -30,000	-75%	-$190K	0.01%	589
2013 Q4	$209K	Buy	40,000 +10,000	+33%	+$45.9K	0.04%	300
2013 Q3	$166K	Buy	+30,000	New	+$104K	0.04%	333

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FineMark National Bank & Trust's PACB Position: Q1 2015 in Review

FineMark National Bank & Trust sold out of Pacific Biosciences (PACB) in Q1 2015, closing a stake of 7,000 shares — an estimated $55K sold.

FineMark National Bank & Trust first reported a position in PACB in Q3 2013 and held it in 4 quarters. The position peaked at $209K in Q4 2013. 94 funds tracked by Wall St. Rank hold PACB as of Q1 2015.

FineMark National Bank & Trust reported no remaining Pacific Biosciences position as of Q1 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 7,000 Pacific Biosciences shares in Q1 2015, an estimated $55K.
FineMark National Bank & Trust first reported a position in Pacific Biosciences in Q3 2013 and held it in 4 quarters.
FineMark National Bank & Trust's Pacific Biosciences position peaked at $209K in Q4 2013.
94 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2015.

Based on FineMark National Bank & Trust's 13F filing for Q1 2015, filed 13 May 2015.